Evidence map›Paper›PMID 40036164›Full record

ArticleEuropean journal of preventive cardiology2025

Higher intakes of dietary dicarbonyl compounds are associated with lower risk of cardiovascular disease.

Ana-Lucia Mayén, Kim Maasen, Claudia Hana, Viktoria Knaze, Jean Scheijen, Simone J P M Eussen, Philippe Vangrieken, Charlotte Debras, Jessica Blanco, Christina C Dahm and 17 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Ana-Lucia MayénNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.ORCID 0000-0001-9635-0416
Kim MaasenDepartment of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Claudia HanaDepartment of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria.
Viktoria KnazeEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Jean ScheijenDepartment of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Simone J P M EussenDepartment of Epidemiology, CAPHRI Care and Public Health Research Institute/CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Philippe VangriekenDepartment of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Charlotte DebrasNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.
Jessica BlancoNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Krasimira AleksandrovaDepartment of Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.ORCID 0000-0002-1275-1827
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Lucia DanseroCentre for Biostatistics, Epidemiology, and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.ORCID 0000-0002-5758-9069
Salvatore PanicoDipartimento Di Medicina Clinica E Chirurgia, Federico Ii University, Naples, Italy.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.ORCID 0000-0001-5201-172X
Marcela GuevaraFEA Med. Prev. y Salud Pública, Instituto de Salud Pública y Laboral de Navarra, Institute of Public and Occupational Health of Navarre, C/Leyre, 15, Pamplona 31003, Spain.ORCID 0000-0001-9242-6364
Conchi Moreno IribasPublic Health Institute of Navarra, Leyre 15, Pamplona-Iruña 31003, Spain.
Dafina PetrovaDepartamento de Registro de Cancer de Granada, Escuela Andaluza de Salud Pública (EASP), Granada 18011, Spain.
Carmen SantiusteCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid 28029, Spain.
Raul Zamora-RosRaul Zamora-Ros, Unit of Nutrition and Cancer, Institut d'Investigació Biomèdica de Bellvitge, Gran Via de l'Hospitalet, 199 08908 L'Hospitalet de Llobregat, Barcelona, España.
Yvonne T van der SchouwJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Elom AglagoDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Inge HuybrechtsNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.ORCID 0000-0003-3838-855X
Heinz FreislingNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.ORCID 0000-0001-8648-4998
Casper SchalkwijkDepartment of Internal Medicine, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.
Mazda JenabNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), 25 Avenue Tony Garnier, 90627 69366 LYON CEDEX 07, Lyon, France.ORCID 0000-0002-0573-1852

Funding

A Healthy Diet for a Healthy Life'Associazione Italiana per la Ricerca sul Cancro-AIRC-ItalyCancer Research UK 14136Cancer Research UK C8221/A29017Catalan Institute of Oncology-ICOCompagnia di SanPaolo and National Research CouncilDanish Cancer SocietyDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College LondonDutch Ministry of Public Health, Welfare and SportsDutch Prevention FundsDutch ZONERA-NET Cofund HDHL INTIMIC 727,565EU Horizon 2020 Research and Innovation ProgrammeEuropean Joint Programming Initiative 'A Healthy Diet for a Healthy Life'Federal Ministry of Education and ResearchGerman Cancer AidGerman Cancer Research CenterGerman Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)Health Research FundHealth Research Fund Fondo de Investigaciones SanitariasInstitut Gustave RoussyInstitut National de la Santé et de la Recherche MédicaleInstituto de Salud Carlos IIIInternational Agency for Research on CancerLigue Contre le CancerMedical Research Council 1000143Medical Research Council MR/M012190/1'Miguel Servet II' CPII20/00009Mutuelle Générale de l'Education NationaleNetherlands Cancer RegistryNIHR Imperial Biomedical Research CentreRegional Governments of Andalucía, Asturias, Basque Country, Murcia and NavarraResearch FundsStatistics NetherlandsThe Swedish Research Council and County Councils of Skåne and VästerbottenWorld Cancer Research FundWorld Health Organization 001
6 · The paper itself

Abstract

aimsDicarbonyl compounds such as methylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone (3-DG) are present in numerous foods. They are pro-inflammatory and pro-oxidative, but their potential role in cardiovascular disease (CVD) development has been scarcely studied. We explored associations between dietary dicarbonyls with fatal and non-fatal CVD. METHODS AND

resultsWe conducted a case-cohort analysis based on 32 873 subjects drawn from 346 055 participants of the multi-national prospective EPIC cohort. Cases (15 863 subjects) were CVD-free at baseline and later developed CVD [coronary heart disease (CHD) and/or stroke] with non-fatal (n CVD = 17 837; n CHD = 12 003; n stroke = 6791; not mutually exclusive) and/or fatal (n CVD = 2894; n CHD = 2284; n stroke = 908) outcomes. Dietary intake of dicarbonyl compounds was estimated using country-specific questionnaires linked to a food composition database of dicarbonyl compounds. Multivariable prentice weighted Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident non-fatal and fatal CVD. The main food sources of dicarbonyl compounds include cereals, sugar and confectionaries, coffee, fruits, and vegetables. Higher dietary dicarbonyl intakes were inversely associated with non-fatal CVD (per 1 SD increase, GO: HR = 0.95, 95% CI 0.92-0.98; 3-DG: HR = 0.95, 95% CI 0.92-0.98), fatal CVD (MGO: HR = 0.92, 95% CI 0.87-0.97; GO: HR = 0.91, 0.86-0.96; 3-DG: HR = 0.93, 0.86-0.99), non-fatal CHD (3-DG: HR = 0.95, 0.92-0.99), non-fatal stroke (MGO: HR = 0.93, 95% CI 0.90-0.96; GO: HR = 0.90, 95% CI 0.86-0.95; 3-DG: HR = 0.92, 95% CI 0.89-0.96), and fatal CHD (MGO: HR = 0.94, 95% CI 0.88-0.99; GO: HR = 0.92, 0.86-0.98; 3-DG: HR = 0.89, 0.82-0.96).

conclusionHigher intakes of dietary MGO, GO, and 3-DG intake are associated with lower risk of non-fatal or fatal CVD. Further research is required to confirm these findings, assess circulating levels of dicarbonyls, and explore potential underlying mechanisms for their observed CVD risk associations. LAY SUMMARY: Dicarbonyl compounds are known to promote oxidative stress, inflammation, endothelial dysfunction, and vascular complications. They are formed endogenously in the body as a byproduct in glucose metabolism but are also present in some foods during food preparation and processing.We studied the role of three major dicarbonyl compounds coming from foods on cardiovascular diseases using data from the prospective EPIC cohort, which includes over 520 000 participants from 10 European countries.We observed that higher consumption of dietary dicarbonyl compounds resulted in a lower risk of non-fatal or fatal CVD.Our findings highlight the need to better understand the roles of these dietary compounds along with their potential underlying mechanisms of action.

Indexed as

Cardiovascular DiseasesDeoxyglucoseDietGlyoxalPyruvaldehydeAgedEuropeFemaleHeart Disease Risk FactorsHumansIncidenceMaleMiddle AgedProspective StudiesProtective FactorsRisk Assessment3-deoxyglucosoneDeoxyglucoseGlyoxalPyruvaldehyde3-deoxyglucosoneadvanced glycation end productscardiovascular diseasecase-cohort studyglyoxalmethylglyoxal

Identifiers

PMID40036164
PMCPMC12600303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.